Registers | British Society for Rheumatology

Overview

BSR operates four biologics and biosimilars registers; three for adult patients and one for children and young adults.

The data collected from the registers generates vital evidence on patient safety in the long term as well as the efficacy of treatment.

Members and non-members can access this data for research purposes – find out more below.

Data requests are regularly reviewed by our Registers' and Research Committee. There are three deadlines by which data requests should be submitted: the end of January, May, and October. To ensure that your data access request is reviewed in a timely fashion, please submit your data access requests prior to these dates.

Requesting registers data

Rheumatoid Arthritis Biologics register for rheumatoid arthritis, operated in partnership with the University of Manchester

Find out more

Psoriatic Arthritis Register for psoriatic arthritis, operated in partnership with the University of Aberdeen

Find out more

Juvenile Idiopathic Arthritis JIA register (Etanercept study) running alongside the BCRD study. Operated in partnership with the University of Manchester

Find out more

Ankylosing Spondylitis Biologic register for ankylosing spondylitis, operated in partnership with the University of Aberdeen

Find out more

Published papers The biologics and biosimilars registers are a rich source of evidence for clinicians and researchers; find papers using registers data here

Find out more

Requesting registers data Find out how you can access and analyse the rich registers datasets that the society holds

Find out more